GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OS Therapies Inc (AMEX:OSTX) » Definitions » Short-Term Debt

OSTX (OS Therapies) Short-Term Debt : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OS Therapies Short-Term Debt?

OS Therapies's Short-Term Debt for the quarter that ended in Sep. 2024 was $0.00 Mil.

OS Therapies's quarterly Short-Term Debt increased from Mar. 2024 ($15.57 Mil) to Jun. 2024 ($16.70 Mil) but then declined from Jun. 2024 ($16.70 Mil) to Sep. 2024 ($0.00 Mil).

OS Therapies's annual Short-Term Debt stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($14.61 Mil).


OS Therapies Short-Term Debt Historical Data

The historical data trend for OS Therapies's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OS Therapies Short-Term Debt Chart

OS Therapies Annual Data
Trend Dec21 Dec22 Dec23
Short-Term Debt
- - 14.61

OS Therapies Quarterly Data
Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only - 14.61 15.57 16.70 -

OS Therapies Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


OS Therapies Short-Term Debt Related Terms

Thank you for viewing the detailed overview of OS Therapies's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


OS Therapies Business Description

Traded in Other Exchanges
N/A
Address
15825 Shady Grove Road, Suite 135, Rockville, MD, USA, 20850
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.